完整原文
While animal experimentation has historically propelled medical advancements, its ethical permissibility in contemporary scientific inquiry warrants rigorous reevaluation. Advocates emphasize that mammalian physiological parallels remain indispensable for complex disease modeling, whereas detractors highlight the escalating availability of computational models and engineered tissue systems that circumvent animal usage. To reconcile these perspectives, regulatory bodies should enforce stringent welfare protocols while mandating phased implementation of validated non-animal methodologies, particularly in cosmetic and agricultural research. Although complete phase-out remains scientifically premature for neuropharmacological studies, the categorical prohibition of pain-inducing procedures in non-medical domains represents a morally imperative step forward. Ultimately, fostering a research ecosystem that prioritizes human relevance without compromising ethical boundaries demands sustained interdisciplinary collaboration and transparent public engagement.